MD–MM achieving third place in the Oncology Track at the Siriraj x MIT Hacking Medicine Hackathon 2026
October 18, 2026 – The College of Management, Mahidol University (CMMU), proudly congratulates Supicha Hanputpakdikul (Grace), a fifth-year medical student in the MD–MM Dual-Degree Program at the Faculty of Medicine Ramathibodi Hospital and the College of Management, Mahidol University, on achieving third place in the Oncology Track at the Siriraj x MIT Hacking Medicine Hackathon 2026. The competition featured 18 competing teams in the Oncology Track and attracted more than 1,100 applicants.
At the competition, Grace’s team, LANA 4.0, presented an innovative clinical trial matching platform designed to connect patients with clinical trials that align with their medical conditions and treatment needs. The platform aims to facilitate timely access to relevant clinical trials, creating opportunities for patients to benefit from advances in precision oncology and personalized treatment.
The innovation addresses a critical challenge in cancer care, particularly for patients with advanced-stage cancer who may face limited treatment options. By helping identify clinical trials that may be suitable for individual patients, the platform seeks to broaden access to emerging treatment opportunities and support more personalized approaches to cancer management.
This achievement highlights the potential of interdisciplinary collaboration among medicine, management, and technology in developing innovative solutions to pressing healthcare challenges. It also underscores the importance of healthcare innovation in improving patient access to clinical research and advancing more personalized, patient-centered cancer care.
CMMU extends its heartfelt congratulations to Grace and the LANA 4.0 team on this remarkable achievement and encourages the continued development of innovative solutions that create meaningful impact on society and the healthcare sector.
At the competition, Grace’s team, LANA 4.0, presented an innovative clinical trial matching platform designed to connect patients with clinical trials that align with their medical conditions and treatment needs. The platform aims to facilitate timely access to relevant clinical trials, creating opportunities for patients to benefit from advances in precision oncology and personalized treatment.
The innovation addresses a critical challenge in cancer care, particularly for patients with advanced-stage cancer who may face limited treatment options. By helping identify clinical trials that may be suitable for individual patients, the platform seeks to broaden access to emerging treatment opportunities and support more personalized approaches to cancer management.
This achievement highlights the potential of interdisciplinary collaboration among medicine, management, and technology in developing innovative solutions to pressing healthcare challenges. It also underscores the importance of healthcare innovation in improving patient access to clinical research and advancing more personalized, patient-centered cancer care.
CMMU extends its heartfelt congratulations to Grace and the LANA 4.0 team on this remarkable achievement and encourages the continued development of innovative solutions that create meaningful impact on society and the healthcare sector.
- Hits: 18